Runners and riders in the Covid vaccine race

Pfizer, AstraZeneca and Moderna have gained acceptance for their Covid vaccines from the British isles regulator and the jabs are previously getting rolled out. But what about the other vaccine candidates and how soon will they come to sector?

Our listing presents a snapshot of what the vaccine landscape appears to be like.

The life sciences industry’s response to the pandemic has been unprecedented equally in phrases of the pace at which it has developed vaccines and its willingness to collaborate with rivals. That has resulted in 237 potential vaccines, of which 64 are in human scientific trials.

That is terrific news as, in the vaccines business there is often no “a single-sizing-suits-all” solution, with distinct nations around the world necessitating distinct sorts of vaccines based mostly on a assortment of variables together with weather, land mass and demography. In other words and phrases: there is loads of room in the sector for more than a single vaccine.

Covid vaccines accepted by the British isles

Pfizer/BioNtech

British isles acceptance date: December 2, 2020

Doses: 2

Efficacy: 90pc +

Style: mRNA

Doses bought or pre-ordered globally: The full sum is undisclosed, but we know it has 300m on buy from the EU and 200m from the US, which, jointly with the British isles, brings the full to 540m

Doses procured by the British isles: 40m

Production functionality: Up to 2bn doses this yr